Spots Global Cancer Trial Database for proteomic profiling
Every month we try and update this database with for proteomic profiling cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Biomarkers in Patients With High-Risk Melanoma Receiving High-Dose Interferon Therapy | NCT00897520 | Melanoma (Skin) | recombinant int... proteomic profi... immunoenzyme te... laboratory biom... | - 120 Years | Eastern Cooperative Oncology Group | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme | NCT00770471 | Brain and Centr... | temozolomide veliparib DNA methylation... gene expression... mutation analys... proteomic profi... high performanc... immunoenzyme te... laboratory biom... mass spectromet... pharmacogenomic... pharmacological... adjuvant therap... radiation thera... | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors | NCT00602082 | Gastrointestina... Islet Cell Tumo... | capecitabine cisplatin streptozocin DNA analysis RNA analysis protein analysi... proteomic profi... laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
| S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia | NCT01338974 | Leukemia | gene expression... proteomic profi... flow cytometry laboratory biom... | 56 Years - | SWOG Cancer Research Network | |
| Biomarkers in Blood and Tissue Samples From Patients With Newly Diagnosed Neuroblastoma | NCT01387724 | Neuroblastoma | RNA analysis polymerase chai... protein express... proteomic profi... western blottin... enzyme-linked i... immunohistochem... laboratory biom... liquid chromato... mass spectromet... | 1 Year - 10 Years | Children's Oncology Group | |
| Duct Endoscopy in Assessing Cellular Atypia in the Breast Duct Fluid of Women With a Genetic Risk for Breast Cancer | NCT00082979 | Breast Cancer | cytogenetic ana... proteomic profi... cytology specim... immunohistochem... laboratory biom... breast duct lav... | 18 Years - 64 Years | National Cancer Institute (NCI) | |
| Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy | NCT01169363 | Leukemia | proteomic profi... flow cytometry laboratory biom... | 60 Years - 120 Years | Eastern Cooperative Oncology Group | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | NCT00559598 | Extrahepatic Bi... Pancreatic Canc... | proteomic profi... medical chart r... | - | National Institutes of Health Clinical Center (CC) | |
| Biomarkers to Detect Mesothelioma Early in Patients Exposed to Asbestos or Vermiculite | NCT00897247 | Malignant Mesot... Pulmonary Compl... | microarray anal... protein express... proteomic profi... laboratory biom... | 25 Years - 80 Years | Barbara Ann Karmanos Cancer Institute | |
| Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy | NCT06416397 | Cholangiocarcin... | Proteomic profi... | 18 Years - | University Hospital, Bordeaux | |
| Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients | NCT00899626 | Colorectal Canc... Esophageal Canc... Gastric Cancer Pancreatic Canc... Precancerous Co... | protein analysi... proteomic profi... biologic sample... laboratory biom... medical chart r... diagnostic colo... diagnostic endo... diagnostic endo... diagnostic surg... endoscopic surg... screening colon... | 18 Years - | Vanderbilt University Medical Center | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Study of Blood and Urine Samples in Patients With Newly Diagnosed Localized Prostate Cancer Treated With Hormone Therapy and Radiation Therapy. ICORG 06-15 | NCT00955435 | Prostate Cancer | Non-interventio... Protein express... Proteomic profi... Laboratory biom... | 18 Years - | Cancer Trials Ireland | |
| Bortezomib, Doxorubicin Hydrochloride Liposome, and Rituximab in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment | NCT00851552 | Lymphoma | rituximab bortezomib pegylated lipos... gene expression... polymerase chai... polymorphism an... proteomic profi... flow cytometry laboratory biom... | 18 Years - | Roswell Park Cancer Institute | |
| Cetuximab & Celecoxib for Metastatic Colorectal Cancer or Colorectal Cancer That Cannot Be Removed by Surgery | NCT00466505 | Colorectal Canc... | cetuximab celecoxib proteomic profi... immunohistochem... laboratory biom... mass spectromet... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease | NCT00898508 | Breast Cancer | gene expression... mutation analys... proteomic profi... reverse transcr... fluorescent ant... immunohistochem... laboratory biom... liquid chromato... mass spectromet... medical chart r... quality-of-life... | 20 Years - | City of Hope Medical Center | |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors | NCT00601289 | Brain and Centr... | temozolomide DNA methylation... microarray anal... protein express... proteomic profi... laboratory biom... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Biomarkers in Urine Samples From Patients With Wilms Tumor | NCT01550393 | Kidney Cancer | proteomic profi... enzyme-linked i... laboratory biom... medical chart r... | - 120 Years | Children's Oncology Group | |
| S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy | NCT01360125 | Leukemia | proteomic profi... flow cytometry laboratory biom... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Irinotecan, Cisplatin, Bevacizumab, Radiation Therapy, and Surgery in Treating Patients With Locally Advanced Esophageal Cancer | NCT00354679 | Esophageal Canc... | bevacizumab cisplatin irinotecan hydr... proteomic profi... diagnostic labo... mass spectromet... adjuvant therap... neoadjuvant the... therapeutic con... radiation thera... | 18 Years - 120 Years | Memorial Sloan Kettering Cancer Center | |
| Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer | NCT00674557 | Breast Cancer | SOD1 inhibitor ... exemestane protein express... proteomic profi... laboratory biom... pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Evaluation of Patients With Breast Cancer Using DCE-MRI, MRS, and Proteomics | NCT00656604 | Breast Cancer | proteomic profi... lumpectomy or m... dynamic contras... histopathologic... magnetic resona... | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy | NCT01360125 | Leukemia | proteomic profi... flow cytometry laboratory biom... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Biomarkers in Blood & Tissue Samples From Patients With Colorectal Cancer or Polyps & Patients Without Polyps | NCT00898378 | Colorectal Canc... Healthy, no Evi... Precancerous Co... | gene expression... polymerase chai... polymorphism an... protein express... proteomic profi... gas chromatogra... laboratory biom... liquid chromato... mass spectromet... questionnaire a... | 18 Years - | Indiana University | |
| Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer | NCT00550537 | Lung Cancer | bevacizumab carboplatin erlotinib hydro... paclitaxel gene expression... protein express... proteomic profi... laboratory biom... | 18 Years - 120 Years | Vanderbilt-Ingram Cancer Center | |
| Molecular Markers in Predicting Lung Cancer Development Using Tissue Samples From Healthy Participants | NCT00899457 | Healthy, no Evi... Lung Cancer | proteomic profi... biologic sample... laboratory biom... bronchoscopy | 18 Years - | Vanderbilt-Ingram Cancer Center | |
| Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors | NCT00389922 | Unspecified Adu... | lapatinib ditos... vinorelbine dit... comparative gen... cytogenetic ana... gene expression... mutation analys... polymerase chai... polymorphism an... proteomic profi... reverse transcr... immunohistochem... laboratory biom... lapatinib ditos... Vinorelbine dit... | 18 Years - | University of California, Davis | |
| Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia | NCT01626183 | Leukemia | RNA analysis proteomic profi... laboratory biom... | - | Children's Oncology Group | |
| Biomarkers in Predicting Neurotoxicity in Patients With Colorectal Cancer Receiving Oxaliplatin | NCT00884767 | Chemotherapeuti... Colorectal Canc... Neurotoxicity | FOLFOX regimen fluorouracil leucovorin calc... oxaliplatin gene expression... protein express... proteomic profi... laboratory biom... pharmacogenomic... | 18 Years - | National Cancer Institute (NCI) | |
| Biomarkers in Urine Samples From Patients With Wilms Tumor | NCT01550393 | Kidney Cancer | proteomic profi... enzyme-linked i... laboratory biom... medical chart r... | - 120 Years | Children's Oncology Group | |
| S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy | NCT01360125 | Leukemia | proteomic profi... flow cytometry laboratory biom... | 18 Years - 60 Years | SWOG Cancer Research Network | |
| Temozolomide in Treating Patients With Invasive Pituitary Tumors | NCT00601289 | Brain and Centr... | temozolomide DNA methylation... microarray anal... protein express... proteomic profi... laboratory biom... | 18 Years - 75 Years | Jonsson Comprehensive Cancer Center | |
| Study of Ductal Lavage in Women at High Risk for Breast Cancer | NCT00429988 | Breast Cancer | fluorescence in... polymerase chai... proteomic profi... cytology specim... immunohistochem... breast duct lav... | 18 Years - | University of California, San Francisco | |
| Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 | NCT01035307 | Leukemia | gene expression... microarray anal... proteomic profi... laboratory biom... | - 20 Years | Children's Oncology Group | |
| Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants | NCT00433485 | Neoplastic Synd... Non-melanomatou... | sirolimus comparative gen... gene expression... microarray anal... protein express... proteomic profi... laboratory biom... mass spectromet... biopsy | 18 Years - 120 Years | Yale University | |
| Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease | NCT00813878 | Breast Cancer | protein analysi... protein express... proteomic profi... diagnostic labo... immunohistochem... liquid chromato... mass spectromet... fine-needle asp... needle biopsy radiomammograph... | 18 Years - 120 Years | City of Hope Medical Center | |
| Diagnostic Approach for Cholangiocarcinoma Using Liquid Bile Biopsy | NCT06416397 | Cholangiocarcin... | Proteomic profi... | 18 Years - | University Hospital, Bordeaux | |
| Study in Predicting Outcome of Patients Undergoing Radiation Therapy for Prostate Cancer | NCT00045331 | Prostate Cancer | proteomic profi... | 18 Years - | National Cancer Institute (NCI) | |
| Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate Cancer | NCT00739791 | Prostate Cancer | exercise interv... gene expression... polymerase chai... proteomic profi... reverse transcr... laboratory biom... medical chart r... questionnaire a... psychosocial as... quality-of-life... support group t... therapeutic die... | - | University of California, San Francisco | |
| Blood Proteins in Finding Pancreatic Cancer and Extrahepatic Biliary Tract Cancer | NCT00559598 | Extrahepatic Bi... Pancreatic Canc... | proteomic profi... medical chart r... | - | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
